InMed Pharmaceuticals (INM) Asset Utilization Ratio (2022 - 2025)

InMed Pharmaceuticals' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.37 for Q4 2025.

• On a quarterly basis, Asset Utilization Ratio fell 27.95% year-over-year to 0.37 in Q4 2025; TTM through Dec 2025 was 0.37, a 27.95% decrease from a year earlier, with the FY2025 full-year figure at 0.36, up 1.72% from the prior year.
• Asset Utilization Ratio climbed to 0.37 in Q4 2025 per INM's latest filing, from 0.33 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.55 in Q1 2025 and bottomed at 0.12 in Q4 2022.
• The 4-year median for Asset Utilization Ratio is 0.37 (2023), against an average of 0.35.
• Across the five-year window, Asset Utilization Ratio jumped 246.64% in 2023 and slipped 27.95% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.12 in 2022, then soared by 246.64% to 0.42 in 2023, then grew by 21.52% to 0.51 in 2024, then declined by 27.95% to 0.37 in 2025.
• Per Business Quant, the three latest INM Asset Utilization Ratio figures stand at 0.37 (Q4 2025), 0.33 (Q3 2025), and 0.4 (Q2 2025).